Ninety One (UK)
AMED

Ninety One (UK)’s Amedisys AMED Stock Holding History

Ninety One (UK)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-120,969
Closed -$18M – 209
2021
Q3 		$18M Sell
120,969
-7,865
-6% -$1.63M 0.05% 152
2021
Q2 		$31.6M Sell
128,834
-8,592
-6% -$2.25M 0.08% 141
2021
Q1 		$36.4M Buy
137,426
+6,876
+5% +$1.94M 0.1% 143
2020
Q4 		$38.3M Sell
130,550
-44,027
-25% -$11.3M 0.12% 135
2020
Q3 		$41.3M Sell
174,577
-12,631
-7% -$2.87M 0.15% 113
2020
Q2 		$37.2M Sell
187,208
-124,342
-40% -$23.2M 0.13% 115
2020
Q1 		$57.2M Buy
+311,550
New +$55.4M 0.24% 83

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Ninety One (UK)'s AMED Position: Q4 2021 in Review

Ninety One (UK) sold out of Amedisys (AMED) in Q4 2021, closing a stake of 120,969 shares — an estimated $18M sold.

Ninety One (UK) first reported a position in AMED in Q1 2020 and held it in 7 quarters. The position peaked at $57.2M in Q1 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Ninety One (UK) reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Ninety One (UK) sold 120,969 Amedisys shares in Q4 2021, an estimated $18M.
  • Ninety One (UK) first reported a position in Amedisys in Q1 2020 and held it in 7 quarters.
  • Ninety One (UK)'s Amedisys position peaked at $57.2M in Q1 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Ninety One (UK)'s 13F filing for Q4 2021, filed 11 Feb 2022.